Researchers at the University of Michigan have demonstrated that a single dose of a psychedelic compound significantly improves cognitive flexibility in mice for at least three weeks after administration. This groundbreaking finding suggests potential therapeutic applications for conditions characterized by cognitive rigidity, including depression, PTSD, and Alzheimer's disease.

Researchers have developed a light-induced DNA detection method that enables rapid, PCR-free genetic analysis. Their technique offers ultra-sensitive mutation detection in just five minutes, reducing costs and simplifying testing. The method has significant potential in healthcare, environmental conservation, and personal health monitoring.

In a Genomic Press Interview, Dr. Jeremie Poschmann of Université de Nantes discusses his pioneering research into the circulating immune system using multi-omics profiling. His work explores how immune history shapes individual responses to infection and psychiatric disorders.

An editorial published in Brain Medicine reveals that many widely prescribed medications may disrupt sterol biosynthesis—an essential process for brain development—potentially causing harm similar to devastating genetic disorders. This urgent call to action highlights how current drug approval processes fail to account for drug interactions that could harm developing brains.